These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 2591015)

  • 1. Modifying effects of simultaneous treatment with butylated hydroxyanisole (BHA) on rat tumor induction by 3,2'-dimethyl-4-aminobiphenyl, 2,2'-dihydroxy-di-n-propylnitrosamine and N-methylnitrosourea.
    Ito N; Hirose M; Shibata M; Tanaka H; Shirai T
    Carcinogenesis; 1989 Dec; 10(12):2255-9. PubMed ID: 2591015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model.
    Hirose M; Takesada Y; Tanaka H; Tamano S; Kato T; Shirai T
    Carcinogenesis; 1998 Jan; 19(1):207-12. PubMed ID: 9472713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation.
    Shirai T; Fukushima S; Kawabe M; Shibata M; Iwasaki S; Tada M; Ito N
    Carcinogenesis; 1991 Jul; 12(7):1335-9. PubMed ID: 1906380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats.
    Imaida K; Fukushima S; Shirai T; Masui T; Ogiso T; Ito N
    Gan; 1984 Sep; 75(9):769-75. PubMed ID: 6500233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of butylated hydroxyanisole pretreatment on low dose N-methyl-N'-nitro-N-nitrosoguanidine- or N,N-dibutylnitrosamine-induced rat forestomach or esophageal carcinogenesis.
    Hirose M; Uwagawa S; Ozaki K; Takaba K; Ito N
    Carcinogenesis; 1991 Oct; 12(10):1773-6. PubMed ID: 1934256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats.
    Imaida K; Fukushima S; Inoue K; Masui T; Hirose M; Ito N
    Cancer Lett; 1988 Dec; 43(3):167-72. PubMed ID: 3203335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis.
    Ito N; Hirose M; Fukushima S; Tsuda H; Shirai T; Tatematsu M
    Food Chem Toxicol; 1986; 24(10-11):1071-82. PubMed ID: 3804112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model.
    Hirose M; Yada H; Hakoi K; Takahashi S; Ito N
    Carcinogenesis; 1993 Nov; 14(11):2359-64. PubMed ID: 8242867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia.
    Shibata MA; Shirai T; Asakawa E; Hirose M; Fukushima S
    Int J Cancer; 1993 Mar; 53(5):819-23. PubMed ID: 8449607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
    Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N
    Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis model.
    Hirose M; Tanaka H; Takahashi S; Futakuchi M; Fukushima S; Ito N
    Cancer Res; 1993 Jan; 53(1):32-7. PubMed ID: 8416747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-carcinogenic effect of retinyl acetate on forestomach carcinogenesis of male F344 rats induced with butylated hydroxyanisole.
    Hasegawa R; Takahashi M; Furukawa F; Toyoda K; Sato H; Hayashi Y
    Jpn J Cancer Res; 1988 Mar; 79(3):320-8. PubMed ID: 3131282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid regression of squamous cell hyperplasia and slow regression of basal cell hyperplasia in the forestomach of F344 rats treated with N-methyl-N'-nitro-N-nitrosoguanidine and/or butylated hydroxyanisole.
    Tatematsu M; Ogawa K; Mutai M; Aoki T; Hoshiya T; Ito N
    Cancer Res; 1991 Jan; 51(1):318-23. PubMed ID: 1703036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model.
    Hirose M; Ozaki K; Takaba K; Fukushima S; Shirai T; Ito N
    Carcinogenesis; 1991 Oct; 12(10):1917-21. PubMed ID: 1657429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats.
    Hagiwara A; Tanaka H; Imaida K; Tamano S; Fukushima S; Ito N
    Jpn J Cancer Res; 1993 Mar; 84(3):237-45. PubMed ID: 8486526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying influence of prior treatment with toxic agents on induction of preneoplastic and neoplastic lesions in a medium-term multi-organ carcinogenesis bioassay.
    Hagiwara A; Tiwawech D; Imaida K; Tamano S; Shibata MA; Fukushima S; Ito N
    Teratog Carcinog Mutagen; 1993; 13(6):277-87. PubMed ID: 7505956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of simple hyperplasia and papillomas and persistence of basal cell hyperplasia in the forestomach of F344 rats treated with butylated hydroxyanisole.
    Masui T; Asamoto M; Hirose M; Fukushima S; Ito N
    Cancer Res; 1987 Oct; 47(19):5171-4. PubMed ID: 3621202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing effects of sodium phenobarbital and N,N-dibutylnitrosamine on tumor development in a rat wide-spectrum organ carcinogenesis model.
    Shibata MA; Fukushima S; Takahashi S; Hasegawa R; Ito N
    Carcinogenesis; 1990 Jun; 11(6):1027-31. PubMed ID: 2347061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.
    Ito N; Fukushima S; Tamano S; Hirose M; Hagiwara A
    J Natl Cancer Inst; 1986 Dec; 77(6):1261-5. PubMed ID: 3467116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats.
    Nera EA; Iverson F; Lok E; Armstrong CL; Karpinski K; Clayson DB
    Toxicology; 1988 Dec; 53(2-3):251-68. PubMed ID: 3212786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.